Understanding how estradiol affects risk-taking behavior in females
Investigation of the neurobiological mechanisms underlying estradiol-mediated risk aversion in females
This study is looking at how the hormone estradiol affects decision-making and risk-taking in females, using rats to see how drug use might change these behaviors, with the hope of improving treatment options for women dealing with addiction.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10811683 on NIH RePORTER |
What this research studies
This research investigates the neurobiological mechanisms that influence decision-making and risk aversion in females, particularly focusing on the hormone estradiol. Using a rat model, the study aims to explore how chronic drug exposure alters the neural pathways that govern risk-taking behavior, which may differ significantly from males. By examining these mechanisms, the research seeks to identify how substance use impacts decision-making processes in females, potentially leading to better treatment strategies for addiction. The findings could help bridge the gap between animal studies and clinical applications, enhancing our understanding of female-specific responses to drugs.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be females who have a history of substance use or are at risk of developing substance use disorders.
Not a fit: Patients who are male or those who do not have a history of substance use may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment approaches for women struggling with substance use disorders by tailoring interventions based on hormonal influences on decision-making.
How similar studies have performed: While there has been significant research on risk-taking behavior in males, this approach focusing specifically on females and the role of estradiol is relatively novel and has not been extensively tested.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Orsini, Caitlin Anne — University of Texas at Austin
- Study coordinator: Orsini, Caitlin Anne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.